Analýza nákladů na léčbu HIV pozitivních

Virus HIV was first diagnosed in 1986 in the Czech Republic. Since then, over a one thousand of people have been infected. The treatment of such patients is very expensive owing to high prices of medicaments. These are influenced especially by high costs of the development of new drugs. The question of financing the costs of treatment of infected people is becoming more and more up-to-date as their number increases every year. In my thesis, I analyse the contemporary situation in terms of the number of patients and costs expended annually on their treatment, as wells as on prevention against the contagion. Further, I focus on concrete ways of treatment in relation to their financial severity and effectiveness. A part of work is also the quantification of public and private sources of financing of the HIV positive treatment. Finally, I attempt to predict the growth of costs associated with the expected rise of the number of diseased and its impact on the health system. The paper will also contain an international comparison.